chr8-144333966-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_031309.6(SCRT1):c.266C>T(p.Thr89Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000331 in 1,209,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031309.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCRT1 | NM_031309.6 | c.266C>T | p.Thr89Ile | missense_variant | 2/2 | ENST00000569446.3 | NP_112599.2 | |
SCRT1 | XM_024447291.2 | c.65C>T | p.Thr22Ile | missense_variant | 2/2 | XP_024303059.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCRT1 | ENST00000569446.3 | c.266C>T | p.Thr89Ile | missense_variant | 2/2 | 1 | NM_031309.6 | ENSP00000455711 | P1 | |
SLC52A2 | ENST00000675888.1 | c.-256G>A | 5_prime_UTR_variant | 1/5 | ENSP00000502294 | P1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000331 AC: 4AN: 1209648Hom.: 0 Cov.: 32 AF XY: 0.00000342 AC XY: 2AN XY: 585540
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2023 | The c.266C>T (p.T89I) alteration is located in exon 2 (coding exon 2) of the SCRT1 gene. This alteration results from a C to T substitution at nucleotide position 266, causing the threonine (T) at amino acid position 89 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at